» Articles » PMID: 32642280

METTL3 Plays Multiple Functions in Biological Processes

Overview
Journal Am J Cancer Res
Specialty Oncology
Date 2020 Jul 10
PMID 32642280
Citations 89
Authors
Affiliations
Soon will be listed here.
Abstract

N-methyladenosine (mA) is the most common internal modification of mRNAs in higher eukaryotic. This process is performed by methyltransferase. Methyltransferase-like 3 (METTL3) is the best known mA methyltransferase that functions in the reversible epi-transcriptome modulation of mA modification. Besides acting as a mA methyltransferase, METTL3 also regulates mRNA translation and other biological processes. In recent years, studies have identified numerous roles and molecular mechanisms associated with METTL3 in multiple biological processes. However, these findings have not been summarized. In this review, we have systematically summarized the most recent important roles of METTL3 in various biological processes, including cell cycle progression, cell proliferation, cell apoptosis, cell migration and invasion, cell differentiation and inflammatory response. In addition, we discuss the prospect of using a METTL3 as a new diagnostic biomarker and therapeutic target for human cancers.

Citing Articles

Methylase METTL3 regulates oxidative stress-induced osteoblast apoptosis through Wnt/β-catenin signaling pathway.

Yang P, Wang H, Meng L, Kou Y, Bu J, Li M J Mol Histol. 2025; 56(2):86.

PMID: 39928245 DOI: 10.1007/s10735-025-10358-x.


The emerging roles of aberrant alternative splicing in glioma.

Ben Mrid R, El Guendouzi S, Mineo M, El Fatimy R Cell Death Discov. 2025; 11(1):50.

PMID: 39915450 PMC: 11802826. DOI: 10.1038/s41420-025-02323-0.


Semaphorin-4D signaling in recruiting dental stem cells for vascular stabilization.

Zhang L, Thalakiriyawa D, Liu J, Yang S, Wang Y, Dissanayaka W Stem Cell Res Ther. 2025; 16(1):25.

PMID: 39865283 PMC: 11770943. DOI: 10.1186/s13287-025-04149-0.


METTL3-dependent DLG2 inhibits the malignant progression of cervical cancer by inactivating the Hippo/YAP signaling.

Pu M, Xiao X, Lv S, Ran D, Huang Q, Zhou M Hereditas. 2025; 162(1):9.

PMID: 39856747 PMC: 11762078. DOI: 10.1186/s41065-025-00365-z.


METTL3: a multifunctional regulator in diseases.

Li N, Wei X, Dai J, Yang J, Xiong S Mol Cell Biochem. 2025; .

PMID: 39853661 DOI: 10.1007/s11010-025-05208-z.


References
1.
Zhang Z, Wang M, Xie D, Huang Z, Zhang L, Yang Y . METTL3-mediated N-methyladenosine mRNA modification enhances long-term memory consolidation. Cell Res. 2018; 28(11):1050-1061. PMC: 6218447. DOI: 10.1038/s41422-018-0092-9. View

2.
Barbieri I, Tzelepis K, Pandolfini L, Shi J, Millan-Zambrano G, Robson S . Promoter-bound METTL3 maintains myeloid leukaemia by mA-dependent translation control. Nature. 2017; 552(7683):126-131. PMC: 6217924. DOI: 10.1038/nature24678. View

3.
Zhang C, Wang Y, Peng Y, Xu H, Zhou X . METTL3 regulates inflammatory pain by modulating mA-dependent pri-miR-365-3p processing. FASEB J. 2020; 34(1):122-132. DOI: 10.1096/fj.201901555R. View

4.
Warda A, Kretschmer J, Hackert P, Lenz C, Urlaub H, Hobartner C . Human METTL16 is a -methyladenosine (mA) methyltransferase that targets pre-mRNAs and various non-coding RNAs. EMBO Rep. 2017; 18(11):2004-2014. PMC: 5666602. DOI: 10.15252/embr.201744940. View

5.
Tran N, Ernst F, Hawley B, Zorbas C, Ulryck N, Hackert P . The human 18S rRNA m6A methyltransferase METTL5 is stabilized by TRMT112. Nucleic Acids Res. 2019; 47(15):7719-7733. PMC: 6735865. DOI: 10.1093/nar/gkz619. View